Thermo Fisher Scientific Inc. Stock Wiener Boerse
Equities
TMOF
US8835561023
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
519.9 EUR | +1.56% | -3.20% | +7.86% |
Sales 2024 * | 43.02B 39.55B | Sales 2025 * | 46.1B 42.37B | Capitalization | 217B 200B |
---|---|---|---|---|---|
Net income 2024 * | 6.12B 5.62B | Net income 2025 * | 6.92B 6.36B | EV / Sales 2024 * | 5.59 x |
Net Debt 2024 * | 23.19B 21.32B | Net Debt 2025 * | 19.14B 17.59B | EV / Sales 2025 * | 5.13 x |
P/E ratio 2024 * |
35.8
x | P/E ratio 2025 * |
30.7
x | Employees | 122,000 |
Yield 2024 * |
0.26% | Yield 2025 * |
0.28% | Free-Float | 86.04% |
Latest transcript on Thermo Fisher Scientific Inc.
1 day | +1.56% | ||
1 week | -3.20% | ||
1 month | -2.77% | ||
3 months | -1.98% | ||
6 months | +14.19% | ||
Current year | +7.86% |
Managers | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01-10-31 |
Director of Finance/CFO | 57 | 01-05-31 | |
Ryan Snyder
CTO | Chief Tech/Sci/R&D Officer | - | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01-10-31 |
C. Harris
BRD | Director/Board Member | 67 | 12-03-29 |
Ruby Chandy
BRD | Director/Board Member | 62 | 22-02-28 |
Date | Price | Change |
---|---|---|
24-06-04 | 523.4 | +0.10% |
24-06-03 | 522.9 | +0.58% |
24-05-31 | 519.9 | +1.56% |
24-05-30 | 511.9 | -2.42% |
24-05-29 | 524.6 | +0.06% |
End-of-day quote Wiener Boerse, May 30, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.83% | 194B | |
+20.48% | 143B | |
+31.33% | 111B | |
+3.08% | 64.3B | |
+14.64% | 52.94B | |
+2.72% | 49.53B | |
-5.88% | 38.31B | |
+0.25% | 35.22B | |
+22.76% | 30.47B |
- Stock Market
- Equities
- TMO Stock
- TMOF Stock